Iodine-125
Showing 1 - 25 of 1,261
AK104 Combined With I-125 Brachytherapy for Recurrent or
Not yet recruiting
- Cervical Cancer
- Iodine-125 particle brachytherapy
- AK104
- (no location specified)
Sep 25, 2023
Metastatic Pancreatic Cancer Trial in Shanghai (Iodine125-Seeds implantation, Gem/nab-P Chemotherapy)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Iodine125-Seeds implantation
- Gem/nab-P Chemotherapy
-
Shanghai, Shanghai, ChinaChanghai Hospital
May 11, 2023
Breast Cancer Trial in Nice (Metal wire, Radioactive Iodine Seed)
Active, not recruiting
- Breast Cancer
- Metal wire
- Radioactive Iodine Seed
-
Nice, FranceCentre Antoine LACASSAGNE
Jan 19, 2023
Recurrent Chest Wall Malignancies After EBRT
Recruiting
- Chest Wall Tumor
- Radioactive Iodine-125 Seeds Implantation
-
Beijing, Beijing, ChinaPeking University Third Hospital
May 31, 2022
Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Lenvatinib Plus I-125 Seed Brachytherapy, Lenvatinib)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- Lenvatinib Plus I-125 Seed Brachytherapy
- Lenvatinib
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Nov 2, 2022
Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus Trial (I-125 Seeds Brachytherapy in PVTT,
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- I-125 Seeds Brachytherapy in PVTT
- +2 more
- (no location specified)
Aug 14, 2023
Prostate Cancer Trial in Grenoble (Interstitial Brachytherapy of the Prostate With Iodine 125 Implant With Target Dose
Not yet recruiting
- Prostate Cancer
- Interstitial Brachytherapy of the Prostate With Iodine 125 Implant With Target Dose Supplementation in the Tumor Volume Guided by the TRINITY® PERINE 3D
-
Grenoble, FranceIsabelle Boudry
Apr 1, 2022
Hepatocellular Carcinoma, Portal Vein Occlusion, Tumor Thrombus Trial in Guangzhou (TACE combined with iodine-125 seeds
Active, not recruiting
- Hepatocellular Carcinoma
- +2 more
- TACE combined with iodine-125 seeds implantation
- TACE
-
Guangzhou, Guangdong, ChinaThe 2nd Affiliated Hospital of Guangzhou Medical University
Mar 2, 2022
Sarcoma,Soft Tissue, Brachytherapy, Poly(ADP-ribose) Polymerase Inhibitors Trial in Guangzhou (Fluzoparib, Radioactive particle
Recruiting
- Sarcoma,Soft Tissue
- +2 more
- Fluzoparib
- Radioactive particle implantation
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 30, 2023
Prostate Cancer Trial in Québec (Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant, Stereotactic Body
Recruiting
- Prostate Cancer
- Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant
- Stereotactic Body Radiation Therapy to the prostate
-
Québec, CanadaCentre Intégré de Cancérologie, CHU de Québec-Université Laval
Sep 21, 2023
Glioblastoma Trial (Iodine-125+Chemotherapy, Surgical resection+Radiochemo)
Not yet recruiting
- Glioblastoma
- Iodine-125+Chemotherapy
- Surgical resection+Radiochemotherapy
- (no location specified)
Jun 28, 2021
3D-PCT Combined With CT-guided Radioactive I-125 Seed
Recruiting
- Malignant Tumor of Head and/or Neck
- Radioactive Iodine-125 Seeds Implantation
-
Beijing, ChinaDepartment of Radiation Oncology of Peking university third hosp
Jul 18, 2022
Radioactive Iodine-125 Brachytherapy, Thoracic Cancer, 3D Printing Coplanar Template Trial in Beijing (Radioactive seed
Recruiting
- Radioactive Iodine-125 Brachytherapy
- +3 more
- Radioactive seed brachytherapy
-
Beijing, Beijing, ChinaPeking University Third Hospital
May 31, 2022
Choroidal Melanoma Trial in Aurora (1000CsK Silicon Oil Tamponade)
Completed
- Choroidal Melanoma
- 1000CsK Silicon Oil Tamponade
-
Aurora, ColoradoUniversity of Colorado Eye Center
Mar 4, 2022
Following Prostate Brachytherapy With Iodine-125 Seeds
Completed
- Prostate Cancer
- Brachytherapy with Iodine-125 seeds
- (no location specified)
Sep 16, 2020
3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent
Recruiting
- Recurrent Rectal Cancer
- +2 more
- CTV
-
Beijing, Beijing, ChinaPeking Unnversity Third Hospital
Jan 13, 2021
PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer
Not yet recruiting
- Prostate Cancer
- permanent brachytherapy
- (no location specified)
Apr 28, 2020
Prostate Cancer Trial in Québec (Permanent Iodine-125 seed implant, High-Dose-rate Prostate Brachytherapy)
Completed
- Prostate Cancer
- Permanent Iodine-125 seed implant
- High-Dose-rate Prostate Brachytherapy
-
Québec, Quebec, CanadaCHU de Québec- L'Hôtel-Dieu de Québec
Feb 8, 2021
Retinoblastoma Trial in France (Melphalan or Melphalan + Topotecan, etoposide, carboplatin and vincristine, Carboplatin
Recruiting
- Retinoblastoma
- Melphalan or Melphalan + Topotecan
- +6 more
-
Saint-Denis, La Réunion, France
- +27 more
Nov 24, 2022
SARS-CoV-2 Infection Trial (Povidone-Iodine Solution 1.25% w/w [0.125% available iodine] USP)
Not yet recruiting
- SARS-CoV-2 Infection
- Povidone-Iodine Solution 1.25% w/w [0.125% available iodine] USP
- (no location specified)
Feb 8, 2021
Pancreatic Cancer Trial in China (3D-printed non-coplanar template, 3D-printed coplanar template)
Unknown status
- Pancreatic Cancer
- 3D-printed non-coplanar template
- 3D-printed coplanar template
-
Hefei, Anhui, China
- +7 more
Feb 5, 2020
Prostate Cancer Trial in France (Radiation by brachytherapy, Radiation by SBRT)
Recruiting
- Prostate Cancer
- Radiation by brachytherapy
- Radiation by SBRT
-
Albi, France
- +15 more
Nov 3, 2022
Hepatocellular Carcinoma, Portal Vein Tumor Thrombus Trial in Shanghai (procedure, device, drug, other)
Unknown status
- Hepatocellular Carcinoma
- Portal Vein Tumor Thrombus
- Stent and Iodine-125 seed strand implantation
- +5 more
-
Shanghai, Shanghai, ChinaDepartment of Interventional Radiology, Zhongshan Hospital, Fuda
Jun 9, 2020
I125 Brachytherapy After TURP
Completed
- Cancer
- I125 brachytherapy
-
Leeds, United KingdomThe Leeds Teaching Hospitals NHS Trust
Aug 16, 2019
Optical Coherence Tomography of Retinal Abnormalities Associated
Terminated
- Ocular Melanoma
-
Los Angeles, CaliforniaJules Stein Eye Institute
Aug 8, 2019